Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PACKER M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 166

  • Page / 7
Export

Selection :

  • and

Research in Classical Studies for University degrees in Great Britain and IrelandPACKER M. M.Institute of Classical Studies Bulletin. 1976, Num 23, pp 131-159Article

SELECTION OF VASODILATOR DRUGS FOR PATIENTS WITH SEVERE CHRONIC HEART FAILURE: AN APPROACH BASED ON A NEW CLASSIFICATIONPACKER M.1982; DRUGS (N. Y.); ISSN 0012-6667; USA; DA. 1982; VOL. 24; NO 1; PP. 64-74; BIBL. 3 P.Article

Calcium channel blockers in chronic heart failure : the risks of physiologically rational therapyPACKER, M.Circulation (New York, N.Y.). 1990, Vol 82, Num 6, pp 2254-2257, issn 0009-7322Article

Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with β-adrenergic agonists and antagonistsPACKER, M.Journal of cardiovascular pharmacology. 1989, Vol 14, pp S38-S43, issn 0160-2446, suppl. 5Conference Paper

Neurohormonal interactions and adaptations in congestive heart failurePACKER, M.Circulation (New York, N.Y.). 1988, Vol 77, Num 4, pp 721-730, issn 0009-7322Article

Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hopePACKER, M.Journal of the American College of Cardiology. 1988, Vol 12, Num 5, pp 1299-1317, issn 0735-1097Article

Current perspectives on the design of phase II trials of new drugs for the treatment of heart failurePACKER, M.The American heart journal. 2000, Vol 139, Num 4, pp S202-S206, issn 0002-8703Conference Paper

β-adrenergic blockade in chronic heart failure : Principles, progress, and practicePACKER, M.Progress in cardiovascular diseases. 1998, Vol 41, Num 1, pp 39-52, issn 0033-0620, SUP1Article

Treatment of chronic heart failurePACKER, M.Lancet (British edition). 1992, Vol 340, Num 8811, pp 92-95, issn 0140-6736Article

Potential role of potasium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failurePACKER, M.The American journal of cardiology. 1990, Vol 65, Num 10, pp 45E-51E, issn 0002-9149Conference Paper

Management of primary pulmonary hypertensionPACKER, M.Developments in cardiovascular medicine. 1988, Vol 83, pp 209-223, issn 0166-9842Article

Pathophysiology of chronic heart failurePACKER, M.Lancet (British edition). 1992, Vol 340, Num 8811, pp 88-92, issn 0140-6736Article

Are nitrates effective in the treatment of chronic heart failure ? antagonist's viewpointPACKER, M.The American journal of cardiology. 1990, Vol 66, Num 4, pp 458-461, issn 0002-9149, 4 p.Article

Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failurePACKER, M.Circulation (New York, N.Y.). 1990, Vol 81, Num 2, pp III.78-III.86, issn 0009-7322Conference Paper

Hormone-electrolyte interactions in congestive heart failure : lessons from a 4,000-year-old sumerian tabletPACKER, M.The American journal of cardiology. 1990, Vol 65, Num 10, pp 1E-3E, issn 0002-9149Conference Paper

The placebo effect in heart failurePACKER, M.The American heart journal. 1990, Vol 120, Num 6, pp 1579-1582, issn 0002-8703, 4 p., p.2Conference Paper

Drug therapy: combined beta-adrenergic and calcium-entry blockade in angina pectorisPACKER, M.The New England journal of medicine. 1989, Vol 320, Num 11, pp 709-718, issn 0028-4793Article

How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind menPACKER, M.Journal of the American College of Cardiology. 1987, Vol 9, Num 2, pp 433-438, issn 0735-1097Article

The Highest Good in Kant's Psychology of MotivationPACKER, M.Idealistic Studies. An International Philosophical Journal Worcester, Mass. 1983, Vol 13, Num 2, pp 110-119Article

SYMPOSIUM ON VERAPAMIL THERAPY FOR ANGINA PECTORISPACKER M; FRISHMAN WH.1982; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1982; VOL. 50; NO 4; PP. 881-928; BIBL. DISSEM.Article

Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice ?PACKER, M.Journal of the American College of Cardiology. 1996, Vol 28, Num 5, pp 1323-1327, issn 0735-1097Article

Dissolving the Paradox of TragedyPACKER, M.The Journal of aesthetics and art criticism. 1989, Vol 47, Num 3, pp 211-219, issn 0021-8529Article

Converting-enzyme inhibition for severe chronic heart failure: views from a skepticPACKER, M.International journal of cardiology. 1985, Vol 7, Num 2, pp 111-120, issn 0167-5273Article

Is the renin-angiotensin system really unnecessary in patients with severe chronic heart failure: the price we pay for interfering with evolutionPACKER, M.Journal of the American College of Cardiology. 1985, Vol 6, Num 1, pp 171-173, issn 0735-1097Article

Vasodilator therapy for primary pulmonary hypertension: limitations and hazardsPACKER, M.Annals of internal medicine. 1985, Vol 103, Num 2, pp 258-270, issn 0003-4819Article

  • Page / 7